Dedicated to advancing the standard of cancer care for companion animals.

MBF Therapeutics Inc. (MBFT) is a veterinary oncology company developing innovative and highly effective immunotherapies for cancer and infectious diseases in companion animals and livestock. Our proprietary checkpoint inhibitor technology, based on the Wistar Institute’s intellectual property, is a platform technology from which multiple innovative prophylactic and therapeutic products will be developed for animal health markets worth over $5BM. We are working with Dr. Hildegund Ertl at the Wistar Institute and veterinary oncologists to develop a cancer vaccine to treat dogs with melanoma.

Industry: Health
Status: Active

Contact Information

http://www.mbftherapeutics.com/

ttillett@mbftherapeutics.com

Thomas Tillett

Co-founder & CEO

Lorraine Keller

Co-founder & CSO